Okamoto et al. applied the gene expression profile chip technology analysis, showing that STAT3 inhibitors can inhibit cell proliferation and VEGF and promote apoptosis, which indicates that STAT3 inhibitors are expected to be a candidate medicine for EM [38]. The gene discussed is VEGFA; the disease is erythema multiforme.